CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease

CAR-T Cells Targeting Epstein-Barr Virus gp350 Validated in a Humanized Mouse Model of EBV Infection and Lymphoproliferative Disease

Epstein-Barr virus (EBV) is a latent and oncogenic human herpesvirus. Lytic viral protein expression plays an important role in EBV-associated malignancies. The EBV envelope glycoprotein 350 (gp350) is expressed abundantly during EBV lytic reactivation and sporadically on the surface of latently inf...

Full description

Bibliographic Details
Main Authors: Constanze Slabik, Maja Kalbarczyk, Simon Danisch, Reinhard Zeidler, Frank Klawonn, Valery Volk, Nicole Krönke, Friedrich Feuerhake, Constanca Ferreira de Figueiredo, Rainer Blasczyk, Henning Olbrich, Sebastian J. Theobald, Andreas Schneider, Arnold Ganser, Constantin von Kaisenberg, Stefan Lienenklaus, Andre Bleich, Wolfgang Hammerschmidt, Renata Stripecke
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Molecular Therapy: Oncolytics
Subjects:
CAR-T cells
EBV
lymphoma
transplantation
PTLD
humanized mice
Online Access:http://www.sciencedirect.com/science/article/pii/S2372770520301224

Internet

http://www.sciencedirect.com/science/article/pii/S2372770520301224

Similar Items